Loading clinical trials...
Loading clinical trials...
A Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731 as Adjunctive Therapy in Virally-suppressed Patients With Chronic Hepatitis B
Conditions
Interventions
ABI-H0731
SOC NUC
+1 more
Locations
21
United States
Cedars-Sinai Medical Center
Beverly Hills, California, United States
Southern California Research Center
Coronado, California, United States
Asia Pacific Liver Center
Los Angeles, California, United States
University of California Los Angeles
Los Angeles, California, United States
Research and Education
San Diego, California, United States
Medical Associates Research Group
San Diego, California, United States
Start Date
June 11, 2018
Primary Completion Date
July 5, 2019
Completion Date
July 5, 2019
Last Updated
February 17, 2021
NCT07417553
NCT02932150
NCT06671093
NCT05853718
NCT06885710
NCT06906016
Lead Sponsor
Assembly Biosciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions